C. Andreu-Oller

An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.

S. Friedman, J. Llovet, M. Solé, 2019, Gastroenterology.

Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.

P. Schirmacher, S. Friedman, P. Boffetta, 2021, Journal of hepatology.

Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials

M. Esteller, V. Mazzaferro, L. Bassaganyas, 2019, British Journal of Cancer.

CXCR2 inhibition enables NASH-HCC immunotherapy

S. Barry, J. Llovet, David McDonald, 2022, Gut.

Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.

V. Mazzaferro, P. Galle, J. Llovet, 2021, Gastroenterology.

Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials

M. Esteller, V. Mazzaferro, L. Bassaganyas, 2019, British Journal of Cancer.

Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.

V. Mazzaferro, P. Galle, J. Llovet, 2022, Gastroenterology.